logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Clinical surveillance for early stage breast cancer : an analysis of claims data.

    Article - En anglais

    This study estimates the costs of clinical follow-up for women with early stage breast cancer and evaluates the effects of patient and provider characteristics on follow-up intensity.

    Claims data were cumulated from 1/1/89 through 4/30/93 for a comprehensive set of follow-up tests (office visits, radiologic, and laboratory) ordered for 222 women diagnosed at a university hospital between 1/1/89 and 12/31/91.

    Aggregated measures of the volume and costs of follow-up over 6 month intervals were expressed in terms of Medicare's 1993 relative value units (RVUs) and their 1993 cost equivalents.

    Excluding the first 6 months, women received on average, 11.7 RVUs of follow-up in the first year (equivalent to a cost of $362), and 9.5 RVUs in the second year ($297).

    In the first year, chest x-rays, clinical chemistry tests, automated hemograms, and bone scans, accounted for 36% of the cost of follow-up. while computerized tomographic scans and magnetic resonance imaging studies accounted for 30%. Multiple regression analysis of the first year data showed that women who received radiation and/or were followed by oncology, were more likely to receive intensive follow-up.

    Age. race, socioeconomic status, insurance, stage, and treatment did not impact follow-up.

    Costs of follow-up for breast cancer are substantial, though much lower than suggested by others.

    Additionally, wide variations in practice are largely unexplained by patient and/or provider characteristics. (...)

    Mots-clés Pascal : Tumeur maligne, Glande mammaire, Stade précoce, Homme, Femelle, Surveillance, Economie santé, Analyse coût, Glande mammaire pathologie

    Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Early stage, Human, Female, Surveillance, Health economy, Cost analysis, Mammary gland diseases

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0447039

    Code Inist : 002B20E02. Création : 10/04/1997.